2B77:F:F-iShares Ageing Population UCITS Acc (EUR)

ETF | Others |

Last Closing

USD 6.61

Change

-0.02 (-0.23)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-14 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

-0.15 (-0.58%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

-0.08 (-0.17%)

USD 115.48B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

-0.05 (-0.10%)

USD 95.20B
SXR8:F iShares Core S&P 500 UCITS ETF..

N/A

USD 88.54B
FRCJ:F UBS MSCI Japan Socially Respon..

-0.03 (-0.14%)

USD 75.49B
EUNL:F iShares Core MSCI World UCITS ..

+0.31 (+0.33%)

USD 72.04B
SXRZ:F iShares VII PLC - iShares Nikk..

+0.05 (+0.02%)

USD 56.16B
XDNY:F Xtrackers MSCI Japan ESG Scree..

-0.03 (-0.23%)

USD 56.02B
VUAA:F Vanguard S&P 500 UCITS Acc

N/A

USD 51.63B
VUSA:F Vanguard Funds Public Limited ..

-0.17 (-0.17%)

USD 51.63B

ETFs Containing 2B77:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 4.52% 48% F 57% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.52% 45% F 51% F
Trailing 12 Months  
Capital Gain -1.08% 25% F 50% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -1.08% 23% F 43% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -1.94% 31% F 41% F
Dividend Return -1.94% 29% F 37% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 3.79% 93% A 98% N/A
Risk Adjusted Return -51.19% 21% F 23% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.